ArticleKidney & blood pressure research2026
Dapagliflozin May Attenuate Podocyte Injury in Diabetic Kidney Disease through Inhibition of Lactate-Mediated H4K12 Lactylation.
Caixia Cui et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.